Caricamento...

B-cell–targeted therapies in relapsing forms of MS

In recent years, there has been a significant increase in the therapeutic options available for the management of relapsing forms of MS. Therapies primarily targeting B cells, including therapeutic anti-CD20 monoclonal antibodies, have been evaluated in phase I, phase II, and phase III clinical tria...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurol Neuroimmunol Neuroinflamm
Autori principali: Dubey, Divyanshu, Forsthuber, Thomas, Flanagan, Eoin P., Pittock, Sean J., Stüve, Olaf
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656409/
https://ncbi.nlm.nih.gov/pubmed/29082296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000405
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !